www.fdanews.com/articles/148690-pfizer-to-buy-otc-rights-to-nexium-for-250-million-upfront

Pfizer to Buy OTC Rights to Nexium for $250 Million Upfront

August 14, 2012

Pfizer has agreed to acquire rights to market AstraZeneca’s popular heartburn drug Nexium for OTC use, paying $250 million up front as well as milestone and royalty payments.
The Wall Street Journal